Introduction {#Sec1}
============

The integrity of genetic information is under constant threat by the tendency of DNA to engage in chemical reactions in its cellular environment. These can damage the DNA in various ways, most frequently by oxidation, alkylation, or deamination of the coding bases (Lindahl and Wood [@CR85]). Damage to DNA bases may affect their base-pairing properties and, therefore, needs to be fixed to maintain the template function of the DNA (Kunz et al. [@CR80]). Many base lesions are pro-mutagenic, i.e., they give rise to genetic mutations if not repaired. One such example is 7,8-dihydro-8-oxoguanine (8-oxoG), a frequent product of DNA oxidation. 8-oxoG tends to base-pair with adenine, thus giving rise to G•C to T•A transversion mutations. Likewise, hydrolytic deamination of cytosine and 5-methylcytosine (5-meC) gives rise to uracil and thymine mispaired with guanine, respectively, causing C•G → T•A transition mutations if not repaired. Alkylation can generate a variety of DNA base lesions comprising O6-methylguanine (6-meG), N7-methylguanine (7-meG), or N3-methyladenine (3-meA). While 6-meG is pro-mutagenic by its property to pair with thymine, 7-meG and 3-meA block replicative DNA polymerases and are therefore cytotoxic (Lindahl and Wood [@CR85]).

These and many other forms of DNA base damage arise in cells at least 10,000 times every day and only the continuous action of specialized DNA repair systems can prevent a rapid decay of genetic information. Single-base lesions are eliminated by base excision repair (BER), a pathway initiated by DNA glycosylases that recognize and excise damaged bases. Base removal by a DNA glycosylase generates a so-called apurinic/apyrimidinic site (AP-site) in DNA, which is then further processed by specific AP-endonuclease, DNA polymerase, and DNA ligase activities to restore the original DNA sequence (Fig. [1](#Fig1){ref-type="fig"}) (Almeida and Sobol [@CR1]). Accordingly, cells lacking DNA glycosylase functions generally show increased levels of base damage in their DNA, elevated mutation rates, and hypersensitivity to specific DNA damaging agents. Surprisingly, however, the phenotype of DNA glycosylase disruptions in mice is usually rather moderate (reviewed in Robertson et al. [@CR131]), the only known exception being the thymine DNA glycosylase (TDG), which was recently reported to be essential for embryonic development in mouse (Cortazar et al. [@CR28]; Cortellino et al. [@CR30]).Fig. 1The core pathway short-patch BER. The base-excision repair pathway addresses single-base lesions (**a**). BER is initiated by a DNA glycosylase, e.g., UNG, specifically recognizing and binding a base lesion. Upon encountering a substrate base, e.g., uracil for UNG, the glycosylase flips the base out of the base-stack into its catalytic site pocket where specific contacts examine the substrate base and position it for nucleophilic attack to the N-glycosidic bond (**b**). Release of the substrate base results in an abasic site (**c**), which is further processed by the AP-endonuclease, APE1, that cleaves the phosphate backbone 5' to the abasic site, producing a 3'OH and a 5'deoxyribose-phosphate moiety (5'dRP) (**d**). Polymerase β (*Polβ*) hydrolyzes the 5'dRP and fills in the single nucleotide gap, which is subsequently sealed by the DNA ligase III (*LigIII*), supported by the scaffold protein XRCC1 (**e**), thus restoring the original base sequence (**f**). The increase of DNA bending from UNG to Polβ might support the directionality of the handover from one BER factor to the next

In this review, we will focus on the mammalian DNA glycosylases, for which we will briefly summarize the key structure--function concepts and discuss their role in the repair of DNA base lesions. We will further elaborate on their newly emerging functions beyond canonical DNA repair, e.g., in innate and adaptive immunity and in DNA methylation control.

DNA glycosylases---an ancient family of DNA repair proteins {#Sec2}
===========================================================

The consideration that cells must possess an ability to remove uracil from DNA, which arises either by misincorporation of deoxyuridine monophosphate (dUMP) during DNA replication or by hydrolytic deamination of cytosine, led to the discovery of an enzyme capable of cleaving uracil--deoxyribose bonds, the uracil N-glycosidase (Ung) in *Escherichia coli* (Lindahl [@CR84]). This finding was followed by the isolation of many other DNA glycosylases in species from all kingdoms of life. Eleven DNA glycosylases have been identified in mammals and these can be subdivided into four structurally distinct superfamilies; the uracil DNA glycosylases (UDGs), the helix-hairpin-helix (HhH) glycosylases, the 3-methyl-purine glycosylase (MPG), and the endonuclease VIII-like (NEIL) glycosylases (Table [1](#Tab1){ref-type="table"}).Table 1Mammalian DNA glycosylases, their main substrates, modes of action, and mutant phenotypesType of base lesionNamePhysiological substratesMono(M)/ bi(B)functionalMouse knockout (ko)/ knockdown (kd) phenotypeUracil in ssDNA dsDNAUNGUracil-N glycosylaseU, 5-FU, ss and dsDNAMko: viable, B-cell lymphomas, disturbed antibody diversificationSMUG1Single-strand-specific monofunctional uracil DNA glycosylase 1U, 5\--hmU, 5-FU, ss and dsDNAMkd: moderate increase in mutation frequency (C → T)Pyrimidine derivates in mismatchesMBD4Methyl-binding domain glycosylase 4T, U, 5-FU, εC, opposite G, dsDNAMko: viable, elevated mutation frequency (C → T)TDGThymine DNA glycosylaseT, U, 5-FU, εC, 5-hmU, 5-fC, 5-caC; opposite G, dsDNAMko: embryonic lethal, aberrant DNA methylation and imbalanced chromatin marks in CpG-rich promotersOxidative base damageOGG18-OxoG DNA glycosylase 18\--oxoG, FaPy, opposite C, dsDNABko: viable, accumulation of 8-oxoG, elevated mutation frequency (G → T)MYHMutY homolog DNA glycosylaseA opposite 8\--oxoG, C or G, 2\--hA opposite G, dsDNAMko: viable, see OGG1Alkylated purinesMPGMethylpurine glycosylase3\--meA, 7-meG, 3-meG, hypoxanthine, *ε*A, ss and dsDNAMko: viable, elevated levels of ethenoA and hypoxanthineOxidized, ring-fragmented or \--saturated pyrimidinesNTHL1Endonuclease III-like 1Tg, FaPyG, 5-hC, 5-hU, dsDNABko: viableNEIL1Endonuclease VIII-like glycosylase 1Tg, FaPyG, FaPyA, 8-oxoG, 5\--hU, 5\--hC, ss and dsDNABko: metabolic syndrome, increased damage levels in mitochondrial DNA; kd: hypersensitive to γ radiationNEIL2Endonuclease VIII-like glycosylase 2As NTHL1 and NEIL1BUnknownNEIL3Endonuclease VIII-like glycosylase 3FaPyG, FaPyA, prefers ssDNABko: normal*U*, uracil; , *A*, adenine; , *T*, thymine; , *C*, cytosine, *G*, guanine; , *ss* single stranded; , *ds*, double stranded; , *5\--hm*, 5\--hydroxymethyl; , *5-FU*, 5-fluorouracil; , *ε*, etheno; , *5-fC*, 5-formylcytosine; , *5-caC*, 5-carboxylcytosine; , *8\--oxoG*, 8\--oxo-7,8-dihydroguanine; , *Tg*, thymine glycol; , *FaPy*, 2,6-diamino-4-hydroxy-5-*N*-methylformamidopyrimidine; , *me*, methyl; , *h*, hydroxyl

The uracil DNA glycosylases {#Sec3}
---------------------------

*E. coli* Ung turned out to be the founding member of a large superfamily of glycosylases, which now includes six subfamilies, three of which are present in the eukarya. Besides the UNG subfamily, these include the mismatch-specific uracil DNA glycosylases (MUGs) (Gallinari and Jiricny [@CR47]) and the single-strand-specific monofunctional uracil DNA glycosylases (SMUGs) (Haushalter et al. [@CR56]). Despite a considerable amino-acid sequence divergence, all UDGs share a common alpha--beta fold structured catalytic domain (Aravind and Koonin [@CR5]).

Members of the UNG subfamily have been characterized in organisms from bacteria and yeasts to humans and large \"eukaryotic\" viruses. These are highly conserved both at the amino-acid sequence and gene structure levels; the yeast and human proteins share 40.3% amino-acid sequence similarity and the human, mouse, and fish genes have identical exon--intron boundaries, indicating that the exon--intron organization has not changed for more than 450 million years (Krokan et al. [@CR79]). Alternative splicing as well as transcription from two distinct start sites gives rise to the specific mitochondrial and nuclear isoforms UNG1 and UNG2 in mouse and human cells (Nilsen et al. [@CR107]). UNG is highly specific for processing of uracil in DNA but also excises DNA-incorporated 5-fluorouracil (5-FU), a uracil analog used in cancer therapy (Pettersen et al. [@CR121]). Interactions with PCNA and RPA target the nuclear UNG2 to sites of DNA synthesis, where its main function is to rapidly excise uracil that gets incorporated opposite from adenine (Otterlei et al. [@CR114]). Accordingly, mouse cells deficient in UNG accumulate \~100-fold increased levels of uracil in their DNA but, notably, do not show a significant mutator phenotype (Nilsen et al. [@CR108]). This is unlike human cells where inhibition of UNG appears to elevate the mutation frequency mildly (Radany et al. [@CR127]). However, mice lacking *Ung* do develop B-cell lymphomas and show disturbances of antibody diversification, implicating a specific function of UNG in processing deamination-induced U•G mismatches at immunoglobulin loci to facilitate somatic hypermutation and class switch recombination (Rada et al. [@CR126]; Nilsen et al. [@CR109]). Consistently, mutations in the human *UNG* gene have been associated with a subgroup of hyper-IgM syndrome patients, showing impaired class switch recombination (Imai et al. [@CR64]).

The MUG subfamily of UDGs emerged with the identification of TDG, an enzyme capable of excising thymine from G•T mismatches. Nonetheless, the family was named after the *E. coli* Mug protein (Gallinari and Jiricny [@CR47]), giving credit to the fact that the G•U rather than the G•T mismatch represents the common most efficiently processed substrate for the members of this subfamily. MUG orthologs have been described in *Schizosaccharomyces pombe*, *Drosophila melanogaster* (Hardeland et al. [@CR53]), and mammals (Neddermann et al. [@CR106]). Crystal structural analyses revealed a striking resemblance in the overall fold of the glycosylase domains of *E. coli* Mug and Ung, despite the absence of a notable sequence similarity (Barrett et al. [@CR10]). Unlike UNG, however, the MUG glycosylases have a spacious and rather non-discriminating active site pocket, accommodating a broad range of substrates including pyrimidine derivates like 5-FU, 5-hydroxymethyluracil (5-hmU), and 3,N4-ethenocytosine (Table [1](#Tab1){ref-type="table"}) (reviewed in Cortazar et al. [@CR27]), and they process these substrates with an extremely low turnover rate (Waters and Swann [@CR159]; Hardeland et al. [@CR51]). Compared to *E. coli* Mug, which consists of the catalytic core only, TDG contains additional N- and C-terminal domains, providing non-specific DNA interaction and regulatory functions (Hardeland et al. [@CR52]; Steinacher and Schär [@CR146]; Baba et al. [@CR7]). Knockout of *Tdg* in mouse is embryonic lethal, suggesting that, unlike other UDGs, it has a non-redundant essential function in embryonic development (Cortazar et al. [@CR28]; Cortellino et al. [@CR30]). TDG-deficient cells do not show increased sensitivity towards agents that would cause TDG-relevant DNA base lesions, nor do they show increased levels of spontaneous mutations (Cortazar et al. [@CR28]), implicating functions beyond canonical DNA repair, which will be discussed below. An involvement of TDG in DNA repair becomes obvious, however, in the processing of the anti-cancer drug 5-FU when incorporated into the DNA. In this special case, the repair activity of TDG does not provide drug resistance as might be expected; excision of the base analog by TDG results in an accumulation of toxic AP-site intermediates and DNA strand breaks and, thus, mediates the DNA-directed cytotoxic effect of 5-FU (Kunz et al. [@CR81]).

SMUG-family glycosylases were initially identified as a uracil-excising activity in *Xenopus*, insect, and human cells (Haushalter et al. [@CR56]). As such, it appears to serve as back-up for UNG in limiting uracil accumulation (U•A) in genomic DNA and in preventing C → T mutation following cytosine deamination (U•G) (Haushalter et al. [@CR56]; An et al. [@CR3]). While *Xenopus* SMUG has a preference for uracil in single-stranded DNA, hence the name "single-strand-specific monofunctional uracil DNA glycosylase", the human homolog processes uracil also in double-stranded DNA (Table [1](#Tab1){ref-type="table"}) (Haushalter et al. [@CR56]; Kavli et al. [@CR76]). SMUGs show only limited amino-acid sequence similarity with members of other UDG subfamilies and the conservation seems restricted to catalytic site residues, showing mosaic features of the UNG and MUG enzymes. Crystallographic analysis of SMUG1 identified a pyrimidine binding pocket topologically similar to other UDGs and implicated a water displacement/replacement mechanism to account for the enzyme\'s preference for uracil over thymine (Wibley et al. [@CR161]). Like TDG, SMUG1 is active on 5-FU but, unlike TDG, appears to protect cells from the cytotoxic effects of the drug as shown in siRNA knockdown experiments (An et al. [@CR4]). Notably, a 5-hmU DNA glycosylase activity originally discovered in calf thymus was later identified as SMUG1 (Cannon-Carlson et al. [@CR25]; Boorstein et al. [@CR20]). So, like TDG, SMUG1 is capable of processing the deamination product of 5-hydroxymethylcytosine (5-hmC), a substrate that has recently gained attention in the context of active DNA demethylation.

Additional subfamilies of UDGs appear to have evolved in archaeal and bacterial organisms thriving under extreme environmental conditions such as high temperature, favoring hydrolytic deamination of cytosine and 5-meC. As these will not be further discussed here, the reader is referred to the excellent classification of the UDG superfamily originally published by Aravind and Koonin ([@CR5]).

The helix-hairpin-helix glycosylases {#Sec4}
------------------------------------

The second superfamily of DNA glycosylases, characterized by a shared helix-hairpin-helix (HhH) domain, comprises a diverse group of enzymes present in organisms throughout all kingdoms of life. Phylogenetic analysis in 94 genomes from bacteria, archaea, and eukaryotes identified six distinct families of HhH DNA glycosylases: Nth (homologs of the *E. coli* EndoIII protein), OggI (8-oxoG DNA glycosylase I), MutY/Mig (A/G-mismatch-specific adenine glycosylase), AlkA (alkyladenine-DNA glycosylase), MpgII (N-methylpurine-DNA glycosylase II), and OggII (8-oxoG DNA glycosylase II) (Denver et al. [@CR33]). The Nth and MutY/Mig family glycosylases as well as some of the MpgII type proteins contain iron--sulfur \[4Fe4S\] clusters that are thought to play a structural role in DNA binding and substrate recognition (Cunningham et al. [@CR31]; Kuo et al. [@CR82]; Guan et al. [@CR48]; Porello et al. [@CR124]; Begley et al. [@CR12]).

The founding member of the Nth family was originally discovered as an endonuclease activity (EndoIII) in *E. coli* (Radman [@CR129]) but then turned out to be a DNA glycosylase with an associated AP-lyase activity. Nth proteins appear to be the most highly conserved subfamily within the HhH glycosylases (Denver et al. [@CR33]). The mammalian homolog, NTHL1 (endonuclease III-like 1), acts on ring fragmented purines or oxidized pyrimidine residues like thymine glycol (Tg), formamidopyrimidine (FaPy), 5-hydroxycytosine (5-hC), and 5-hydroxyuracil (5-hU), preferentially when placed opposite guanine (Table [1](#Tab1){ref-type="table"}) (Dizdaroglu et al. [@CR37]; Eide et al. [@CR39]). *Nth1* knockout mice show no overt abnormalities presumably because the loss of its repair function can be compensated for by NEIL glycosylases (see below) (Ocampo et al. [@CR110]; Takao et al. [@CR149])*.*

MutY was first identified in *E. coli* as an enzyme excising adenine from A•G mispairs (Au et al. [@CR6]), while Mig.Mth was discovered in hyperthermophilic archaea by its ability to excise U or T mispaired with G (Horst and Fritz [@CR63]). MutY/Mig homologs are widespread in bacterial genomes, but only about half of the eukaryotes and less than a third of the archaeal species analyzed have glycosylases of this family (Denver et al. [@CR33]). The mammalian homolog of MutY, termed MYH, excises adenine opposite 8-oxoG, guanine, or cytosine (Table [1](#Tab1){ref-type="table"}) (McGoldrick et al. [@CR94]), contributing to a multimodal defense against the mutability of guanine oxidation (van Loon et al. [@CR157]). Facilitating the replacement of A opposite 8-oxoG with a C, MYH produces the preferred substrate for the 8-oxoG directed DNA glycosylase OGG1. Hence, disruption of *Myh* in mice does not produce a mutator phenotype *per se* because it is masked by OGG1, which corrects the bulk of oxidized guanines before replicative DNA polymerases get a chance to misinsert adenine opposite the damaged base. Knocking out both *Myh* and *Ogg1*, however, results in a synergistic increase in G → T mutations (Russo et al. [@CR134]). In humans, germline mutations in the *MYH* gene have been associated with a predisposition to colorectal cancer (Al-Tassan et al. [@CR2]; Jones et al. [@CR69]).

The Ogg1 protein family is less well represented across the phylogeny. While present in most eukaryotic genomes, Ogg1 encoding genes seem to be missing in bacteria and archaea (Denver et al. [@CR33]). Ogg1 was originally discovered in yeast and later also identified in mammals (Nash et al. [@CR104]; Lu et al. [@CR88]; van der Kemp et al. [@CR156]; Radicella et al. [@CR128]), where it provides the major activity for the removal of 8-oxoG opposite cytosine (Friedberg et al. [@CR42]). It does, however, also excise other oxidized pyrimidines or ring-fragmented purines like formamidopyrimidine (FaPy) (Table [1](#Tab1){ref-type="table"}) (Dherin et al. [@CR34]; Karahalil et al. [@CR74]). In *Saccharomyces cerevisiae*, inactivation of *OGG1* results in an accumulation of G → T transversion mutations (Thomas et al. [@CR150]). *Ogg1* null mice are viable but exhibit a 2-fold increase in chromosomal 8-oxoG and moderately elevated spontaneous mutation frequencies (Klungland et al. [@CR78]). Polymorphisms in the human *OGG1* gene impairing the 8-oxoG incision activity were found to be associated with non-small cell lung cancer (Janik et al. [@CR68]) and an increased risk of childhood acute lymphoblastic leukemia (Stanczyk et al. [@CR145]).

Although closely related to the Nth and MutY proteins, MBD4, also known as MED1, is special in two ways; it has a methyl-CpG binding domain (MBD) and is therefore also a member of the MBD protein family, and it functionally interacts with MLH1, a protein of the postreplicative mismatch repair system (Hendrich and Bird [@CR59]; Bellacosa et al. [@CR15]). Like the structurally unrelated TDG, MBD4 is a mismatch-directed DNA glycosylase processing a wide range of G-mispaired base lesions, including thymine, uracil, 5-FU, and 3,N4-ethenocytosine (Table [1](#Tab1){ref-type="table"}) (Petronzelli et al. [@CR120]; Cortellino et al. [@CR29]). Its methyl-CpG binding domain in addition to its activity on the deamination product of 5-meC has made MBD4 a prime candidate for an active DNA demethylase, an epigenetic function likely to be important in embryogenesis. However, *Mbd4* knockout mice show no developmental defects, but a mild increase in C → T mutation frequency and a predisposition to gastrointestinal cancer in APC-deficient tumor models (Millar et al. [@CR98]; Wong et al. [@CR166]), consistent with a role of MBD4 in repair of cytosine or 5-meC deamination damage.

*E. coli* AlkA, the founding member of the AlkA family of HhH glycosylases, acts on alkylated bases, e.g., 3-meA. While homologs are present in many bacterial and eukaryotic genomes (Denver et al. [@CR33]), mammals appear to be devoid of this particular class of enzyme. Instead, they use a structurally unrelated enzyme, MPG, to eliminate specific forms of base alkylation damage.

The 3-methyl-purine glycosylase (MPG) {#Sec5}
-------------------------------------

MPG, also known as AAG or MDG, originally identified in rat (O\'Connor and Laval [@CR112]) and later in human, is a DNA glycosylase excising a range of alkylated bases from DNA, including 3-meA, 7-meG, 3-methylguanine (3-meG) as well as ethylated bases in single- and double-stranded DNA (Table [1](#Tab1){ref-type="table"}) (O\'Connor [@CR111]; Lee et al. [@CR83]). MPGs form a structurally distinct class of glycosylases; they lack helix-hairpin-helix motifs nor do they have an alpha--beta fold structure characteristic of UDGs. Mice lacking MPG are viable and show a mild increase in the frequency of spontaneous mutation (Engelward et al. [@CR40]; Hang et al. [@CR50]), and they are more prone to develop azoxymethane-induced colon cancer than their wild-type counterparts (Wirtz et al. [@CR165]). Reminiscent of TDG's role in the DNA-directed cytotoxic effect of 5-FU, MPG drives alkylation-induced retinal degeneration in mice by generating cytotoxic BER intermediates (Meira et al. [@CR95]).

The endonuclease VIII-like glycosylases {#Sec6}
---------------------------------------

Although their substrate spectrum overlaps with that of endonuclease III (Nth), the homologs of *E. coli* endonuclease VIII, encoded by the *nei* gene, are structurally related to the formamidopyrimidine-DNA glycosylase Fpg and form a separate family of DNA glycosylases. Nei was discovered in *E. coli* as a second activity next to Nth acting on thymine glycol (Tg) and urea (Melamede et al. [@CR96]).

The mammalian counterparts are termed Nei-like (NEIL) 1, 2, and 3, and share a conserved helix-two-turn-helix motif with the *E. coli* Fpg and EndoVIII proteins. The preferred substrates of NEIL1 and NEIL2 are oxidized pyrimidines such as Tg, 5-hC, FaPyA, and FaPyG (Hazra et al. [@CR57]; Morland et al. [@CR102]; Rosenquist et al. [@CR132]), but also 5-hydroxyuracil (5-hU) and 8-oxoG in DNA bubble structures (Table [1](#Tab1){ref-type="table"}) (Dou et al. [@CR38]). NEIL3, on the other hand, excises FaPy but is inactive on 8-oxoG (Liu et al. [@CR87]). Mice with a targeted inactivation of the *Neil1* gene exhibit a phenotype reminiscent of the metabolic syndrome, as well as increased levels of DNA damage in mitochondrial DNA (Vartanian et al. [@CR158]). *Neil3* knockout mice are viable and fertile, and the protein appears to be preferentially expressed in hematopoietic tissues (Torisu et al. [@CR152]), implicating a possible function in hematopoiesis or the immune system.

Structure function aspects {#Sec7}
==========================

DNA glycosylases evolved to counter the many different forms of chemical damage occurring to DNA bases. They are highly specialized enzymes with distinct structures and substrate specificities, but they all share a common principle of action. DNA glycosylases recognize their cognate substrates by rotating bases out of the DNA helix into a specifically fitting pocket that harbors the active site. Substrate selectivity is mostly achieved by steric exclusion from the binding pocket of bases that are not to be processed, and to some extent also by the catalytic efficiency of the active site configuration. If base fitting is successful, cleavage of the N-glycosidic bond will occur, resulting in the release of a free base and the generation of a base-less sugar, an AP-site in the DNA.

Detection and verification of base damage {#Sec8}
-----------------------------------------

Detecting a single damaged base in a vast excess of regular bases in the genome amounts to the proverbial task of searching a needle in a haystack, and this is not helped by the fact that the lesions addressed by BER do not usually cause notable distortions to the DNA helix. A human cell suffers about 10^4^ base lesions per day, translating into roughly one lesion every 10 s within a genome of about 14 billion nucleotides that must be spotted and repaired. How DNA glycosylases manage to efficiently search for and recognize these lesions is not clear but biochemical and structural work has provided some insight into possible mechanisms.

### Scanning the genome for damaged bases {#Sec9}

Little is known about how DNA glycosylases find damaged bases in the genome. One idea, proposed on the basis of biochemical evidence and theoretical considerations, postulates the association of the glycosylase with undamaged DNA by non-specific interactions, facilitating sliding along the DNA duplex for a certain distance and scanning the sequence for irregular bases (Berg et al. [@CR16]). Considering the structural and functional diversity of DNA glycosylases, however, there are likely to be different translocation mechanisms, variably involving features of tracking, diffusion, and hopping on the DNA (Blainey et al. [@CR18]; Steinacher and Schär [@CR146]; Friedman and Stivers [@CR44]). Recently, an appealing DNA scanning concept was proposed for DNA glycosylases harboring an \[4Fe4S\] cluster. The underlying observation was that *E. coli* MutY and Nth change the oxidation state of their iron--sulfur cluster from \[4Fe4S\]^2+^ to \[4Fe4S\]^3+^ upon contact with DNA, which stabilizes the interaction. Thus, if such DNA glycosylases bind in the vicinity of each other, they might act as electron donors and acceptors for each other, making use of the DNA for charge transfer. This may facilitate the dissociation of one glycosylase upon binding of another by reduction of its \[4Fe4S\] cluster. If the electron transfer involved is perturbed by a base lesion between the two glycosylases, however, both will stay bound to the DNA, increasing the likelihood of damage detection (Boal et al. [@CR19]). This way, \[4Fe4S\] clusters may support the search for base damage without a need of scanning the entire DNA sequence.

Detection of DNA base damage by DNA glycosylases ultimately requires a full examination of the chemical surface of single bases. To minimize the effort, DNA glycosylases employ strategies of damage pre-selection. OGG1 and UNG, for instance, were proposed to pre-select substrates by establishing superficial base contacts through conserved residues in close proximity to the mouth of their catalytic pocket. This allows potential substrates to be identified without fully inserting every base into the active site pocket (Fig. [2](#Fig2){ref-type="fig"}) (Banerjee et al. [@CR8]; Parker et al. [@CR117]). Consistently, NMR studies on human UNG showed the glycosylase to undergo a conformational change upon DNA binding, allowing for oscillation between an open form, loosely interacting with the DNA in an unspecific manner, and a closed form engaged in base examination without fully rotating the base out of the helix (Fig. [2](#Fig2){ref-type="fig"}) (Friedman et al. [@CR45]). Base pre-scanning is likely to be facilitated by DNA breathing, considering that many base lesions affect base pairing dynamics to some extent and are therefore likely to enhance local DNA melting.Fig. 2Mechanism of base removal by monofunctional and bifunctional glycosylases. While all DNA glycosylases share a common principle of action, they differ in details of damage search, recognition, and excision. Among the monofunctional DNA glycosylases, UNG searches for uracil in DNA by oscillating between an open conformation, making unspecific contacts with the DNA, and a closed conformation for base-interrogation (**a**), involving conserved structures at the mouth of the catalytic site pocket (**b**). Pre-selected bases are flipped out of the DNA duplex and inserted into the catalytic pocket, where specific hydrogen bonds align the base for nucleophilic attack by an activated water molecule strategically positioned by a conserved aspartic acid residue (*red asterisk*, **c**). TDG differs from UNG by its non-specific interaction with DNA through a clamp formed by the N-terminal domain (**a**), its larger catalytic pocket that accommodates a broader range of substrates, and its ability to involve the opposing base in lesion recognition (**b**). The catalytic residue in TDG is an asparagine (*black asterisk*) that positions, but does not activate, a water molecule which can then act as a weak nucleophile (**c**). TDG stays firmly bound to the abasic site upon base release (**d**) until SUMOylation induces dissociation by neutralizing the N-terminal DNA binding activity (**e**). Similar to UNG, the bifunctional OGG1 pre-selects bases for flipping by interactions with conserved amino-acid residues at the mouth of the catalytic cavity (**a**, **b**), and similar to TDG, it also takes the opposing base into account for substrate selection (**c**). Bifunctional glycosylases use a conserved amino-acid residue (*blue asterisk*) for nucleophilic attack, which results in a covalent intermediate between the glycosylase and the DNA substrate (**d**). Resolution of this intermediate produces a DNA nick that is further processed by APE1 (**e**)

### Formation of a mature enzyme substrate complex {#Sec10}

For final damage verification, the base needs to be flipped out of the DNA helix and accommodated in the active site cavity of the glycosylase. This increases the surface for molecular interactions, providing for a sensitive discrimination of even minor base alterations and, ultimately, catalysis of the base release. One of the best-studied glycosylases with regard to damage recognition is UNG. On its surface, UNG forms a positively charged groove that accommodates the minor groove of the DNA and contains the active site cavity. Upon encountering a uracil in DNA, UNG uses a hydrophobic side chain of a conserved leucine to push the uracil out of the base stack and insert it into the catalytic pocket (Fig. [3](#Fig3){ref-type="fig"}). The same residue stabilizes the double helix by occupying the vacated space (Mol et al. [@CR100]; Savva et al. [@CR135]). At the same time, UNG pinches and compresses the double-stranded DNA backbone, thereby inducing DNA bending by about 45° at the site of the damage (Fig. [1](#Fig1){ref-type="fig"}) (Parikh et al. [@CR115]). Selectivity for uracil is mediated by several structural features: purine bases are sterically excluded from the active site by the overall narrow geometry of the binding pocket, while the entry of thymine and other 5-methylated pyrimidines is blocked by a side chain of a conserved tyrosine residue. Accordingly, UNG can be converted into a thymine-processing enzyme by an amino acid substitution that eliminates this sterical block (Kavli et al. [@CR75]). Cytosine can enter the active site but, due to unfavorable hydrogen bonding at the bottom of the cavity, cannot be positioned correctly for catalysis (Kavli et al. [@CR75]; Slupphaug et al. [@CR144]).Fig. 3The base-flipping intermediate captured in a crystal structure of substrate bound human UNG. The UNG double mutant L272R/D145N, stabilizing the glycosylase--substrate complex, was co-crystallized with an oligonucleotide bearing a U•G mismatch. Uracil (red) is flipped into an extrahelical position (**a**) and inserted deeply into the tight fitting active site pocket of UNG (**b**), where it is positioned by specific molecular interactions for the nucleophilic attack on the N-glycosidic bond (Slupphaug et al. [@CR144])

While UNG is highly specialized to the excision of DNA uracil, TDG is a good example of a broad spectrum UDG showing mismatch dependency. Unlike UNG, the bacterial and human TDG orthologs have rather spacious pyrimidine-binding pockets, accommodating a large variety of base derivatives (Barrett et al. [@CR10], [@CR11]; Baba et al. [@CR7]; Maiti et al. [@CR91]), although the preferred substrates are G-mismatched deaminated pyrimidines (Waters and Swann [@CR159]; Hardeland et al. [@CR53]). Because TDG acts on thymine, it needs to be able to discriminate between a regular thymine in DNA (A•T) and one that resulted from deamination of 5-meC (G•T). Substrate selection thus has to take into account not only the base structure itself but also the opposite base. Structural and biochemical studies of *E. coli* Mug and human TDG (Barrett et al. [@CR10]; Maiti et al. [@CR91], [@CR92]) have shed light on how this might be achieved. In contact with DNA, TDG undergoes a conformational change in its N-terminal domain, forming a clamp-like structure that permits TDG to track along the DNA (Fig. [2](#Fig2){ref-type="fig"}) (Steinacher and Schär [@CR146]). Upon encountering a G-mismatched substrate (G•T), the substrate base is pushed out of the DNA helix by an insertion loop wedging into the DNA helix. This same wedge stabilizes the base stack and forms specific hydrogen bonds with the widowed guanine, mimicking Watson--Crick base pairing (Barrett et al. [@CR10], [@CR11]; Maiti et al. [@CR91]). These interactions then cooperate with the non-specific DNA binding activity of the N terminus to stabilize the TDG--substrate complex for efficient base excision (Hardeland et al. [@CR51]; Steinacher and Schär [@CR146]).

Another DNA glycosylase well studied with regard to damage recognition is OGG1. Following successful pre-selection of a potential 8-oxoG substrate (Fig. [2](#Fig2){ref-type="fig"}) (Banerjee et al. [@CR8]), the oxidized base is flipped into the active site cavity of OGG1, inducing DNA bending of about \~70° due to a tyrosine residue that wedges between the opposing C and its 5′ neighbor. Unstacking of the widowed C facilitates enzyme--DNA contacts that maintain opposite base selectivity. The void generated by 8-oxoG rotation is occupied by a conserved asparagine residue, which contributes to hydrogen bonding with the opposing cytosine. While A, C, and T are excluded from the active site pocket by several strategically positioned amino-acids, a conserved glycine is the only residue discriminating between G and 8-oxoG (Bruner et al. [@CR22]).

Catalysis of base removal {#Sec11}
-------------------------

The catalytic mechanism subdivides DNA glycosylases into monofunctional and bifunctional enzymes (Table [1](#Tab1){ref-type="table"}). Monofunctional glycosylases perform base excision only, using an activated water molecule for nucleophilic attack on the N-glycosidic bond, while bifunctional glycosylases use an amino group of a lysine side chain for the same purpose, forming a Schiff-base intermediate, and subsequently cleave the DNA backbone 3′ to the lesion.

### Monofunctional DNA glycosylases {#Sec12}

To illustrate the monofunctional mode of action, we will focus on UNG and TDG as two well-studied UDGs showing contrasting catalytic features. Upon recognition, uracil is tightly fitted into the active site pocket of UNG (Fig. [3](#Fig3){ref-type="fig"}). Interactions between the uracil and amino-acid residues at the bottom of the pocket position the N-glycosidic bond for hydrolysis (Mol et al. [@CR100]; Savva et al. [@CR135]; Slupphaug et al. [@CR144]). Structure and mutational analyses have established a catalytic mechanism involving the polarization of the N-glycosidic bond by a conserved histidine to make it susceptible for nucleophilic attack, and the positioning and deprotonation of a water molecule by a conserved catalytic aspartate, which then attacks the C1 of the deoxyribose (Fig. [2](#Fig2){ref-type="fig"}) (Mol et al. [@CR100]; Slupphaug et al. [@CR144]). N-glycosidic bond cleavage is completed by addition of the water nucleophile to uracil, resulting in a free base and an AP-site.

The mismatch-specific uracil glycosylases, e.g., Mug and TDG, interact less specifically with the substrate base within the catalytic pocket and use a less potent mechanism of catalysis, as first revealed in the crystal structure of *E. coli* Mug (Barrett et al. [@CR10], [@CR11]). In place of the catalytic aspartate in UNG, Mug/TDG enzymes have an asparagine. This asparagine positions a water molecule but, unlike the aspartate in UNG, is unable to protonate it for an efficient nucleophilic attack on the N-glycosidic bond (Fig. [2](#Fig2){ref-type="fig"}). Also, an appropriate residue for polarization of the N-glycosidic bond appears to be missing in Mug/TDG, altogether explaining the comparably low catalytic efficiency of the MUG enzymes (Hardeland et al. [@CR51]; Maiti et al. [@CR92]). These differences illustrate that the mode of catalysis can vary considerably even within one DNA glycosylase superfamily, most likely reflecting the requirement to fine tune substrate spectrum and catalytic efficiency in the evolution of subfamilies with distinct biological functions.

### Bifunctional DNA glycosylases {#Sec13}

DNA glycosylases that use an amino group of a lysine side chain as a nucleophile for base cleavage form a covalent Schiff-base intermediate with the substrate. The resolution of this reaction intermediate incises the DNA 3′ to the product AP-site, generating a strand break with 3′ phosphate and 5′ OH ends. Thus, these enzymes couple base excision with an AP-lyase step, as best illustrated by the bifunctional mechanism proposed for OGG1 (Sun et al. [@CR147]; Nash et al. [@CR105]). Once an 8-oxoG is stably fitted in the active site cavity of OGG1, the side chain amino group of a suitably positioned catalytic lysine is activated as a nucleophile to attack the C1 of the deoxyribose. The resulting rearrangement to a covalent Schiff-base intermediate releases the damaged base from the DNA, which is then held in position to further participate in the catalysis of the β-lyase reaction, cleaving the DNA strand at the 3′ phosphate. Notably, all steps of the OGG1 catalyzed base release involve the transfer of protons and this is promoted by the excised base itself (Bruner et al. [@CR22]; Fromme et al. [@CR46]). An interesting variation on the bifunctional mode of action is displayed by the mammalian NEIL proteins and their *E. coli* counterpart Nei. These enzymes couple base excision to beta and delta elimination, incising the DNA strand both 3′ and 5′ to the AP-site (Takao et al. [@CR149]). Moreover, unlike OGG1, *E. coli* Nei ejects the excised base from the catalytic site immediately, i.e., is capable to perform the AP-lyase reaction without contribution of the damaged base (Zharkov et al. [@CR168]).

AP-site dissociation and turnover of glycosylases {#Sec14}
-------------------------------------------------

Upon base release, DNA glycosylases tend to stay bound to the product of their action, the AP-site. In fact, many glycosylases display a higher affinity to AP-sites than to their actual substrate base (Parikh et al. [@CR115]; Waters et al. [@CR160]; Hardeland et al. [@CR51]; Hill et al. [@CR61]; Pope et al. [@CR122]). The release of the glycosylase from the AP-site is thus rate limiting in the BER process (Fig. [1](#Fig1){ref-type="fig"}). Since AP-sites are chemically unstable and lack base coding potential, the binding of the glycosylase might serve to protect cells against their cytotoxic and mutagenic effects. This considered, it appears reasonable that the release of the AP-site is coordinated with the recruitment and assembly of the downstream acting BER factors. Consistently, the AP-endonuclease APE1 was reported to stimulate the turnover of several DNA glycosylases including UNG2, TDG, and OGG1 (Parikh et al. [@CR115]; Waters et al. [@CR160]; Hill et al. [@CR61]), and a similar effect was observed for the XPC protein on TDG and SMUG1 (Shimizu et al. [@CR141], [@CR142]). It remains to be clarified, though, to what extent these stimulatory effects reflect active processes or simply a passive competition for a common DNA substrate.

Another, perhaps more sophisticated, way to regulate AP-site interaction of the glycosylase is by posttranslational modification. In this direction, UNG2 was reported to be cell cycle specifically phosphorylated at serine 23, which markedly increases its association with replicating chromatin but also its turnover rate, apparently to facilitate efficient correction of misincorporated uracil during ongoing DNA replication (Hagen et al. [@CR49]). In the case of TDG, which binds AP-sites very rigidly, dissociation is regulated by modification of a C-terminal lysine residue with small ubiquitin-like modifiers (SUMOs). This induces a conformational change that neutralizes the non-specific DNA-binding capacity of its N-terminal domain, thereby facilitating AP-site dissociation (Fig. [2](#Fig2){ref-type="fig"}) (Hardeland et al. [@CR52]; Steinacher and Schär [@CR146]). SUMO modification might be triggered by the presence of downstream acting BER factors, providing for a controlled handover of the AP-site intermediate in the repair process (R. Steinacher and P. Schär, unpublished data).

It appears to be a general feature of DNA glycosylases to bend DNA upon establishing a mature enzyme--substrate complex; UNG for example induces a bend of \~45° (Parikh et al. [@CR115]), OGG1 of even \~70° (Bruner et al. [@CR22]). On the basis of these and similar observations with other BER factors, it was proposed that the DNA bending might serve as a structural determinant to orchestrate the handover from one step in the repair process to the next (Fig. [1](#Fig1){ref-type="fig"}) (Parikh et al. [@CR116]; Wilson and Kunkel [@CR163]).

Functions of DNA glycosylases beyond DNA repair {#Sec15}
===============================================

Although DNA glycosylases are optimally suited for the repair of damaged DNA bases, their structural and biochemical properties would support a much wider spectrum of genetic functions. The ability to recognize and excise chemically modified bases can be used to edit the DNA at specifically marked sites. The UDG superfamily in particular appears to comprise enzymes with specialized functions, e.g., in innate immunity and antibody diversification, as well as in the regulation of gene expression and epigenetic maintenance.

DNA glycosylases in immunity {#Sec16}
----------------------------

UDGs haven been functionally associated with mechanisms providing innate immunity against viral infection as well as antibody diversity in the adaptive immune system. All these processes are triggered by enzymatic deamination of cytosine by members of the apolipoprotein B mRNA editing catalytic polypeptide (APOBEC) family of proteins, including the activation-induced cytidine deaminase (AID) (Conticello et al. [@CR26]).

### DNA glycosylases providing innate immunity {#Sec17}

Proteins of the human APOBEC3 subfamily were shown to inhibit replication of a variety of retroviruses, including human immunodeficiency viruses (HIV) (reviewed in Holmes et al. [@CR62]). APOBEC3G was discovered by its ability to restrict replication of a mutant HIV-1 lacking the viral infectivity factor (Vif) (Sheehy et al. [@CR140]). Cells infected with such a virus package APOBEC3G into HIV-1 virions. When these infect new cells, APOBEC3G will deaminate multiple cytosines in the viral cDNA during reverse transcription, which inactivates the provirus (reviewed in Holmes et al. [@CR62]). While APOBEC3G appears to intervene with the viral life cycle at several steps, the antiviral activity mediated by uracilation of the viral genome is coupled to the action of UNG2 and APE1. UNG2 is thought to introduce AP-sites into the deaminated viral cDNA, triggering the cleavage and thus degradation by APE1 (Harris et al. [@CR55]; Yang et al. [@CR167]). Consistently, inhibition and/or downregulation of either UNG2 or APE1 was shown to decrease the antiviral potency of APOBEC3G (Yang et al. [@CR167]). Given that HIV-1 evolved Vpr, a small protein specifically targeting UNG2 and SMUG1 for degradation by the ubiquitin--proteasome system, supports a critical role of uracil base excision in antiviral defense (Schrofelbauer et al. [@CR137], [@CR138]).

### DNA glycosylases providing adaptive immunity {#Sec18}

The cooperation of cytidine deaminase and UDG activities is also central to the genetic transactions associated with antibody diversification in the adaptive immune system, i.e., somatic hypermutation (SHM) and class switch recombination (CSR) (Fig. [4](#Fig4){ref-type="fig"}) (Muramatsu et al. [@CR103]; Rada et al. [@CR126]).Fig. 4Uracil DNA glycosylase in antibody diversification. UNG plays a central role in somatic hypermutation (SHM) and class switch recombination (CSR). UNG2 is targeted to immunoglobulin loci in activated B-cells by AID converting cytosine to uracil in single-stranded DNA during transcription. While replication across unprocessed uracil itself will generate C → T mutations, uracil excision by UNG provides for a wider range of mutations both at the C•G and nearby A•T base pairs; (1) by generating non-instructive AP-sites which, upon DNA replication give rise to transition or transversion mutations, (2) by initiating long-patch BER or, (3) following cleavage by APE1, by providing a DNA strand nick for activation of MMR. Error-prone synthesis associated with long-patch BER and MMR would then produce mutations at A•T base pairs. Similarly, DNA strand breaks occurring through BER of deaminated cytosines in switch regions of immunoglobulin heavy chain loci may induce CSR (*blue panel*)

SHM introduces point mutations in the light chain variable (V) region of immunoglobulin loci. Mutagenesis is initiated by AID, which is targeted to these loci to deaminate multiple cytosines in single-stranded DNA occurring during transcription (reviewed in Pavri and Nussenzweig [@CR118]). Mutations can arise from these U•G mismatches in several ways (Fig. [4](#Fig4){ref-type="fig"}): (1) in the absence of uracil excision, replication across the U•G mismatch would generate a C → T mutation in one of the daughter strands; (2) uracil excision by a UDG and subsequent replication across the resulting AP-site can potentially give rise to any type of base substitution at the site of deamination, although replicative DNA polymerases preferentially insert A opposite an AP-site; (3) long-patch BER, initiated by a UDG, or MMR coupled to error-prone DNA synthesis would cause mutations in proximity to the deaminated cytosine, allowing for mutations to occur also at A•T base pairs.

An involvement of UNG2 in antibody diversification was first implicated by a general perturbance of both SHM and CSR in an UNG2 inhibited chicken B-cell line as well as in UNG-deficient mice (Di Noia and Neuberger [@CR35]; Rada et al. [@CR126]). While the loss of UNG mainly affected SHM at G•C base pairs, inactivation of the mismatch repair system (MMR) was found to diminish hypermutation at A•T pairs (Rada et al. [@CR125]; Wiesendanger et al. [@CR162]). This suggested that error prone MMR contributes to mutagenesis at sites away from the deaminated cytosine (Wilson et al. [@CR164]). Later work then implicated that MMR can indeed operate at an AID induced G•U mismatch if assisted by UNG2, providing a nick at a nearby G•U for initiation of strand excision (Frieder et al. [@CR43]; Schanz et al. [@CR136]).

AID, UNG2, and APE1 were also shown to play a crucial role in the initiation of CSR, a specialized recombination process switching the Ig isotype of an antibody without affecting its antigen specificity. CSR rearranges the antibody constant region of heavy chain genes (C~H~) by strand breakage in and joining of two selected switch (S) regions located upstream of every C~H~-coding segment. The DNA strand breaks required for initiation of CSR were shown to arise through cytosine deamination, subsequent uracil excision, and AP-site cleavage by AID, UNG2, and an AP-endonuclease, respectively (Fig. [4](#Fig4){ref-type="fig"}) (Imai et al. [@CR64]). Consistently, murine B-cells lacking UNG2 show a severe reduction of CSR and in humans, recessive mutations in the *UNG* gene have been associated with the hyper-IgM syndrome caused by a deficiency in CSR (Rada et al. [@CR126]; Imai et al. [@CR64]). It is also reported, however, that the catalytic activity of UNG2 is dispensable for efficient CSR, while an N-terminal sequence motif appears to be important, suggesting that UNG2 is not responsible for the DNA cleavage step of CSR (Begum et al. [@CR13], [@CR14]). It is possible that UNG2 simply marks AID-induced G•U mismatches for further processing by other factors, whereby the N terminus is required to mediate specific protein--protein interactions.

Residual CSR and SHM in UNG2-deficient mice hint at a possible contribution of other UDGs. Indeed, overexpression of SMUG1 in MSH2 UNG2 double-deficient cells could partially restore SHM and CSR. A biological role of SMUG1 in antibody diversification, however, is questionable as it is downregulated upon B-cell activation (Di Noia et al. [@CR36]). Likewise, the U•G mismatch-directed glycosylase MBD4 is unlikely to play a major role in either SHM or CSR as a knockout of the gene in mouse showed no effect on either processes (Bardwell et al. [@CR9]). The situation is less clear for TDG. While the impact of a TDG-deficiency on antibody diversification remains to be investigated, its upregulation in activated mouse B-cells hints at a specific function in B-cell maturation (Christophe Kunz and Primo Schär, unpublished data). In this context, TDG might be simply required to prevent mutations at non-Ig genes arising from mistargeted AID. It might, however, also directly contribute to SHM and CSR. Considering its tight interaction with AP-sites, TDG would be optimally suited to delay processing of these repair intermediates, thereby favoring error-prone translesion synthesis and recombination repair.

DNA glycosylases in DNA methylation control {#Sec19}
-------------------------------------------

Distinct patterns of DNA methylation and histone modifications are established during cell lineage restriction to determine and maintain cell-type-specific gene expression programs. In mammals, DNA methylation occurs mainly in the form of 5-meC in CpG dinucleotide sequences and is controlled by a methylation machinery consisting of both methylating and demethylating components. While the *de novo* establishment and the maintenance of CpG methylation can be rationalized by the biochemical features of the DNA methyltransferase (DNMT) activities involved (Hermann et al. [@CR60]), the reverse process of demethylation has remained elusive. In principle, however, DNA demethylation can be achieved through active and/or passive mechanisms. Whereas passive demethylation occurs upon DNA replication with downregulation or inhibition of the maintenance DNA methyltransferase, active demethylation describes the enzymatic removal of 5-meC and replacement with C. Active mechanisms have been implicated in several important biological processes, including the demethylation of the paternal pronucleus in the murine zygote (Mayer et al. [@CR93]; Oswald et al. [@CR113]), the genome-wide methylation erasure and reset of parental imprinting during gametogenesis (Monk et al. [@CR101]; Kafri et al. [@CR72]), and the reprogramming of methylation patterns observed after transfer of somatic cell nuclei to enucleated oocytes (Dean et al. [@CR32]; Simonsson and Gurdon [@CR143]). Active demethylation has also been reported to be targeted to select gene regulatory regions during neurogenesis, memory formation, and immune response (Bruniquel and Schwartz [@CR23]; Miller and Sweatt [@CR99]; Ma et al. [@CR89]).

Mechanistically, the conversion of 5-meC to C in DNA can occur in different ways: (1) by a direct removal of the methyl group, (2) the replacement of 5-meC with C by excision repair, or (3) the deamination or oxidation of 5-meC followed by replacement of the nucleotide by BER. Consistent with an excision repair scenario, an increasing number of observations point at an engagement of DNA glycosylases in active demethylation. In plants, the removal of 5-meC by at least four bifunctional DNA glycosylases is well established; ROS1, DEMETER (DME), and the DME-like (DML) 2 and 3 all process 5-meC in CpG and non-CpG sequence contexts (reviewed in Zhu [@CR169]). Mutations in these glycosylases affect cytosine methylation at specific loci but not in the overall genome, suggesting that they act in a targeted rather than a global manner (Penterman et al. [@CR119]; Lister et al. [@CR86]). In vertebrates, the situation is less clear; MBD4 and TDG have been implicated in DNA demethylation but they do not seem to be potent enough to excise 5-meC directly.

### Concepts of DNA glycosylase-mediated demethylation in vertebrates {#Sec20}

First evidence for an involvement of DNA glycosylases in active demethylation in vertebrates came with the discovery of a 5-meC DNA glycosylase activity in extracts of chicken embryos (Jost et al. [@CR70]). The responsible enzyme later revealed itself as a homolog of the human TDG (Zhu et al. [@CR171]). 5-meC DNA glycosylase activity was then also reported for the human TDG and MBD4 proteins by the same group (Zhu et al. [@CR170], [@CR172]). Yet, as several attempts to reproduce these finding were unsuccessful, the idea of TDG and MBD4 acting as demethylating glycosylases did not achieve broad acceptance. Recent observations, however, indicate that the difficulty in reproduction might lie in the necessity of unknown co-factors that either boost the catalytic efficiency of these glycosylases or convert 5-meC into a more favorable substrate.

MBD4 was recently reported to control CpG methylation in the context of parathyroid (PTH) hormone-induced gene activation. This was shown for the *CYP27B1* promoter, which undergoes active demethylation upon hormone stimulation (Kim et al. [@CR77]). Both promoter activation and cytosine demethylation coincided with and depended on the physical association of MBD4 and downstream BER factors, but not of the functionally related TDG. Remarkably, this study further showed that phosphorylation of MBD4 by PKC may potentiate its activity to process 5-meC, suggesting that posttranslational modification might be required to unleash a potentially harmful but dormant 5-meC glycosylase activity in certain DNA glycosylases for targeted demethylation under specific conditions (Fig. [5a](#Fig5){ref-type="fig"}). This might apply as well to TDG, given its propensity to posttranslational modification by SUMOylation (Hardeland et al. [@CR52]), ubiquitylation (Hardeland et al. [@CR54]), phosphorylation (Um et al. [@CR154]), and acetylation (Tini et al. [@CR151]). It will thus be necessary to revisit TDG\'s activity as a 5-meC glycosylase under conditions that support the formation of these posttranslational modifications.Fig. 5Possible pathways of active DNA demethylation involving BER. Enzymatic removal of 5-meC has been suggested to be accomplished by different DNA glycosylase mediated mechanisms. Direct excision of 5-meC by mammalian DNA glycosylases has been tested with contradicting results, suggesting the possibility that posttranslational modification might induce a shift in the substrate spectrum, allowing for the removal of 5-meC. (**a**) Another possibility is the enzymatic conversion of 5-meC to substrates more favorable to DNA glycosylases, such as deamination to thymine (**b**), hydroxylation to 5-hydroxymethylcytosine (**c**) and/or further oxidation or deamination of 5-hmC to 5-formylcytosine (5-fC) and 5-carboxylcytosine (5-caC) (**d**) or 5-hydroxymethyluracil (**e**), respectively. All these processes could be accomplished by a cooperation of 5-meC deaminases like AID, hydroxylases like the TET proteins, and DNA glycosylases like TDG (G•T, G•5hmU, G•fC, G•caC), MBD4 (G•T, ?) and possibly SMUG1 (G•T, G•5hmU, ?)

Other lines of investigation support demethylation scenarios that involve the conversion of 5-meC to more favorable substrates for DNA glycosylases. Deamination of 5-meC by a cytidine deaminase is one possibility. This would generate a G•T mismatch that can be acted on by MBD4 or TDG (Fig. [5b](#Fig5){ref-type="fig"}). Along these lines, it was shown that the estrogen responsive pS2/TFF1 promoter undergoes cyclic DNA methylation and demethylation during transcriptional activation, involving 5-meC deamination by the methyltransferase Dnmt3a/b itself and subsequent TDG-dependent BER (Metivier et al. [@CR97]; Kangaspeska et al. [@CR73]). The demethylation complex also includes the RNA helicase p68, implicating an RNA component in either targeting and/or stabilization of the complex, consistent with previously reported observations on the chicken 5-methylcytosine DNA glycosylase (Jost et al. [@CR71]; Schwarz et al. [@CR139]). Additional support for a deamination-coupled demethylation pathway came from a study in zebrafish embryos, implicating AID in the deamination of 5-meC and MBD4 in the excision of the resulting G•T mismatch, as well as Gadd45 as an auxiliary factor (Rai et al. [@CR130]). The same concept was adopted more recently to explain TDG-mediated 5-meC demethylation as it may occur during somatic differentiation of the developing mouse embryo (Cortellino et al. [@CR30]). This, however, was mainly inferred from the co-immunoprecipitation of overexpressed AID and Gadd45 with TDG and therefore needs to be corroborated by more direct functional evidence. Finally, an AID-dependent and, thus, deamination-mediated mechanism has been associated with global DNA demethylation occurring in primordial germ cells as well as during the reprogramming of somatic cell nuclei towards pluripotency (Bhutani et al. [@CR17]; Popp et al. [@CR123]). Obviously, genome-wide 5-meC deamination would generate massive amounts of G•T mismatches, and all of these would have to be repaired by the G•T-directed DNA glycosylases MBD4 or TDG. A strong prediction of a deamination-based demethylation model is therefore that a failure of G•T repair would result in genome-wide C → T mutagenesis. This has not been observed so far in MBD4 and/or TDG-deficient cells (Cortazar et al. [@CR28]) and will have to be tested more carefully.

The recent discovery of DNA dioxygenases acting on 5-meC in DNA introduced another conceptual framework for active demethylation. The principle of oxidative demethylation of DNA bases was first described for the bacterial DNA repair protein AlkB. AlkB belongs to a large superfamily of Fe(II)/2-oxoglutarate (2-OG)-dependent hydroxylases and catalyzes the hydroxylation of N-methylated bases like 1-methyladenine (1-meA) and 3-methylcytosine (3-meC), ultimately resulting in demethylation upon release of the hydroxymethyl moiety as formaldehyde (Falnes et al. [@CR41]; Trewick et al. [@CR153]). The superfamily of Fe(II)/2-OG hydroxylases also contains the kinetoplastid base J binding proteins (JBP). Base J stands for β-[d]{.smallcaps}-glucosyl(hydroxymethyl)uracil, an abundant base in the genome of kinetoplastida, synthesized through a 5-hmU intermediate generated by enzymatic hydroxylation of thymine by JBP1/2 (reviewed in Borst and Sabatini [@CR21]). Computational analyses identified the mammalian oncogenic TET proteins as close relatives of the JBPs (Iyer et al. [@CR67]). The ultimate finding that TETs comprise a catalytic domain capable of catalyzing the oxidation of 5-meC to 5-hmC uncovered a functional link between these proteins and DNA methylation, possibly demethylation (Tahiliani et al. [@CR148]; Ito et al. [@CR65]). Indeed, 5-hmC was suggested to trigger passive demethylation through inhibition of the maintenance methyltransferase DNMT1 (Valinluck and Sowers [@CR155]). Besides that, 5-hmC might represent an intermediate of active DNA demethylation through stepwise oxidation of 5-meC coupled to either excision repair or decarboxylation (Fig. [5d](#Fig5){ref-type="fig"}).

Direct excision of 5-hmC by a DNA glycosylase would seem a plausible scenario (Fig. [5c](#Fig5){ref-type="fig"}). A 5-hmC DNA glycosylase was reported to be active in calf thymus extracts (Cannon et al. [@CR24]). The responsible protein, however, has never been purified, nor has 5-hmC glycosylases activity been associated with any known mammalian DNA glycosylase. Given their activity on 5-hmU, TDG and SMUG1 would seem good candidates for 5-hmC processing, but recent evidence shows that at least TDG fails to do so at an appreciable rate (He et al. [@CR58]; Maiti and Drohat [@CR90]). Thus, while direct 5-hmC excision by DNA glycosylases may occur and contribute to DNA demethylation, the underlying enzymatic pathway remains to be clarified.

Another possible route of demethylation would be the further conversion of 5-hmC to an intermediate for DNA glycosylase mediated excision. The deamination of 5-hmC by a specific deaminase (e.g., AID), for example, would give rise to 5-hmU mismatched with G (Rusmintratip and Sowers [@CR133]), which is a substrate for SMUG1 and TDG (Fig. [5e](#Fig5){ref-type="fig"}) (Boorstein et al. [@CR20]; Hardeland et al. [@CR53]; Cortellino et al. [@CR30]). As discussed above for 5-meC deamination, however, the concept of demethylation through a pro-mutagenic 5-hmU intermediate is debatable as this would require an immensely efficient and accurate coupling of the deamination and repair processes, particularly in densely methylated DNA sequences, if genome integrity is to be maintained.

Less problematic in this regard seems a more recently implicated mode of TET-mediated demethylation. The key discovery was that TET proteins do not only generate 5-hmC but can oxidize this intermediate further to 5-formylcytosine (5-fC), and 5-carboxylcytosine (5-caC) (Ito et al. [@CR66]), which are good substrates for excision by TDG (He et al. [@CR58]; Maiti and Drohat [@CR90]) (Fig. [5d](#Fig5){ref-type="fig"}). Given this, a DNA glycosylase-mediated conversion of 5-meC to C may thus occur without a need to deaminate, i.e., to generate a mutagenic intermediate. However, such a pathway would still trigger massive DNA incision activity in the context of genome-wide active demethylation, which seems a genetically risky and energetically wasteful way to erase an epigenetic mark. A more straightforward way to eliminate 5-caC under these conditions would be to couple the 5-meC oxidation cascade with a decarboxylation step to generate C and CO~2~ as final products. A 5-caC decarboxylase is thus an activity to watch out for.

### G•T-directed DNA glycosylases and epigenetic stability {#Sec21}

Active demethylation of 5-meC in mammalian cells occurs under different circumstances for different purposes, such as genome-wide epigenetic reprogramming, activation of tissue-specific genes during embryogenesis, and the maintenance of active and bivalent chromatin states during and after cell-lineage commitment. These circumstances generate specific demands for a demethylation mechanism (e.g., targeting, catalysis, processivity, efficiency) which are most likely addressed by distinct pathways.

Any of the above considered routes of DNA repair-mediated active demethylation of 5-meC requires an enzyme capable of recognizing and excising a cytosine derivative (5-meC, 5-hmC, 5-caC, T, 5-hmU) in a base (mis)pairing configuration with guanine. On the basis of their substrate spectra, the two DNA glycosylases MBD4 and TDG appear to be most suitable for this purpose, and both have been implicated in one way or another in DNA demethylation as discussed. The biological functions associated with these activities, however, still need to be clarified. Considering, for instance, the reported involvement of MBD4 in hormone-induced promoter demethylation, and the requirement of such demethylation for derepression of select genes during embryogenesis, it is surprising that *Mbd4* knockout mice develop normally and display no apparent epigenetic abnormality (Millar et al. [@CR98]; Wong et al. [@CR166]). So, either promoter demethylation during embryogenesis is not developmentally important, or MBD4 is not or only redundantly involved in these processes. The phenotype of *Tdg* knockout mice, however, has provided more direct evidence for an epigenetic function.

Disruption of TDG in mouse causes embryonic lethality (Cortazar et al. [@CR28]; Cortellino et al. [@CR30]), most likely because TDG-deficient cells fail to properly establish and/or maintain cell-type-specific gene expression programs during cell lineage commitment (Cortazar et al. [@CR28]). This phenotype coincides with the occurrence of aberrant chromatin modifications at promoters of misregulated genes: a loss of active histone marks (H3K4me^2^), a gain of repressive histone marks (H3K9me^3^, H3K27me^3^) and, *nota bene*, a gradual accumulation of CpG methylation (Cortazar et al. [@CR28]). Together with evidence for a TDG-dependent engagement of BER at affected gene promoters (Cortazar et al. [@CR28]; Cortellino et al. [@CR30]), this suggests that TDG protects CpG-rich promoters from aberrant hypermethylation by active demethylation of erroneously methylated cytosines.

TDG may also contribute to active demethylation of originally methylated sequences. Tissues of TDG deficient embryos showed hypermethylation at the *Alb1* enhancer and the *Tat* glucocorticoid-responsive unit, both undergoing demethylation in the process of tissue specific gene activation (Cortellino et al. [@CR30]). These results can, however, be interpreted in two ways; while the hypermethylation measured in the absence of TDG can indeed be explained by inefficient active CpG demethylation during tissue differentiation, it can equally well be accounted for by a lack of TDG-dependent maintenance of the unmethylated state following successful active demethylation through a different pathway. Hence, while the concept of TDG-mediated active demethylation in the maintenance of hypomethylated states at CpG-rich gene promoters is well supported, its potential contribution to demethylation of methylated sequences requires further validation.

The functions of MBD4 and TDG in mediating DNA demethylation are clearly distinct but there might be a partial overlap; TDG might compensate for the loss of MBD4 in knockout mice but obviously not *vice versa*. A plausible scenario would be that MBD4 is primarily involved in the demethylation of methylated sequences in the context of developmental gene activation, whereas TDG's function is to protect unmethylated promoter sequences across the genome from aberrant *de novo* methylation. This would be supported by the ability of MBD4 to bind to methylated CpGs, and the preferential association of TDG with unmethylated gene promoters.

Conclusion {#Sec22}
==========

Given their ability to interrogate the surface of DNA bases by flipping them out of the helix into a selective active site pocket, DNA glycosylases represent efficient tools to specifically recognize unduly modified bases and eliminate them from the DNA, thereby enforcing genetic integrity. Yet, while being perfectly equipped to function in DNA repair, their structure and mode of action could provide for more. This is supported by accumulating evidence for non-canonical functions of these DNA-probing enzymes, the most recent and most intensely discussed being an involvement in DNA demethylation and epigenetic control. Further studies will shed light on the mechanism surrounding the action of DNA glycosylases in such a context, from the signals required for the temporal and spatial regulation of their action to the co-factors necessary for efficient base-flipping and excision.
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